|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07F 9/12 | |
| A61K 31/661 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3298021 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16725997.7 |
| Europos patento paraiškos padavimo data | 2016-05-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/033099 |
| Data | 2016-05-18 |
| (87) | Numeris | WO 2016/187316 |
| Data | 2016-11-24 |
| (30) | Numeris | Data | Šalis |
| 201562163188 P | 2015-05-18 | US |
| (72) |
SIDDIQUI-JAIN, Adam, US
BEARSS, David, J., US
|
| (73) |
Tolero Pharmaceuticals, Inc.,
2975 W. Executive Parkway, Suite 320, Lehi, UT 84043,
US
|
| (54) | ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY |
| ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY |